ReichertLab retweeted
Humbled and ecstatic to organize the India | EMBO Lecture Course on mitochondrial biology in Hyderabad, 26–30 July 2027!
A fantastic lineup of eminent scientists from across the globe!
Looking forward to exciting science and collaborations!
meetings.embo.org/event/27-m…
Stem cells experiencing a minor exposure to doxorubicin show primarily mitochondrial alterations and transfer a 'memory' of this to cardiomyocytes derived from them. Thanks to all collaborators. nature.com/articles/s41536-0…
ReichertLab retweeted
So excited our paper on mitochondrial phosphatidylinositol (PI) is finally out and chosen as an Editor’s Highlight in @NatureComms! PI is a known component of mitochondrial membranes, yet how its levels within mitochondria shape core functions, is unknown.
nature.com/articles/s41467-0…
Congrats
Our paper is now out in Science! Super excited to share our discovery that #mitochondria #pearling is the elusive mechanism driving the regular distribution and inheritance of #mtDNA nucleoids 🧬 [1/6]
ReichertLab retweeted
The glycolytic metabolite phosphoenolpyruvate restricts cGAS-driven inflammation to promote healthy aging | Nature Aging nature.com/articles/s43587-0…
ReichertLab retweeted
NAD+ hydrolysis catalyzed by SelO is required for mitochondrial homeostasis: Cell cell.com/cell/fulltext/S0092…
ReichertLab retweeted
Regulatory T cells thrive in ammonia-rich tumors dlvr.it/TRQ4hh
ReichertLab retweeted
Excited to share our new Nature Communications paper: FLEXTAG — an ultra-small (12–18 kDa, ~½ GFP) self-renewable protein labeling system for anti-fading multi-color super-resolution imaging. Works in both live and fixed cells. nature.com/articles/s41467-0… #Microscopy #CellBiology
ReichertLab retweeted
Out today in @cellcellpress new work from the lab led by Abby Xie and @jules_stef asks, when and why do cells use the TCA cycle?
PhD Position Opening!
We are looking for a highly motivated PhD student aiming to decipher the role of cristae membrane dynamics in controling metabolism. Please apply to our group.
ReichertLab retweeted
Hey, mito Twitter community (whoever is left here). Can you please help me amplify this message? Postdoc position available in Düsseldorf!
ReichertLab retweeted
🚨 New from our lab (est. 2020) — now published in Nature Communications!
🧬We uncover a surprising link between the v-ATPaseand mitochondrial function:
Mild v-ATPase inhibition restores cell fitness under mitochondrial mistranslation stress
nature.com/articles/s41467-0…
(Thread ⬇️)
A long journey which started more than 10 years ago and finally is out. Great team work with the Escobar-Henriques Lab.
Online Now: Ubiquitin precursor with C-terminal extension promotes proteostasis and longevity dlvr.it/TNFK9q
ReichertLab retweeted
Have a look at our joint study with the #Philipp Lang Lab @HHU_de @MedHHU @KondadiLab revealing how cristae morphology affects viral replication, immune metabolism and immunity. Thanks to all collaborators. cell.com/cell-reports/fullte…
Have a look at our joint study with the #Philipp Lang Lab @HHU_de @MedHHU @KondadiLab revealing how cristae morphology affects viral replication, immune metabolism and immunity. Thanks to all collaborators. cell.com/cell-reports/fullte…
ReichertLab retweeted
Mitochondrial fumarate inhibits Parkin-mediated mitophagy dlvr.it/TLWFgR
ReichertLab retweeted
Noga Preminger @Noga_Preminger, Ben Zucker, Sarah Hassdenteufel, Michael Kozlov, Maya Schuldiner & colleagues identify mitochondrial inner membrane remodelling as a driving force of organelle shaping using their data-driven biophysical model.
journals.biologists.com/jcs/…
#OpenAccess
ReichertLab retweeted
Also honored to see our work highlighted in @Nature! Huge thanks to Navdeep S. Chandel and Ram P. Chakrabarty for the fantastic News & Views piece, describing the unexpected role of Ogdh and alpha-ketoglutarate in intestinal healing
nature.com/articles/d41586-0…
ReichertLab retweeted
Thrilled to share our newest publication in Materials & Design doi.org/10.1016/j.matdes.202…: combinational treatment of the antimalarial drug chloroquine and nanoceria selectively kills triple negative breast cancer (TNBC) cells in a 2D and 3D cell system. To all authors: well done
























